Clinical Trial Update: A Trial of 0.025 Wire Guided Cannulation Versus Current Practice 0.035 Wire Guided Cannulation [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing 0.025 wire-guided cannulation to the current practice 0.035 wire-guided cannulation during ERCP has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Pain
• Pancreatitis

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Abdominal Pain, Post-ERCP Acute Pancreatitis | Phase 4 | Status: COMPLETED